Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-041718
Filing Date
2017-08-09
Accepted
2017-08-09 16:35:22
Documents
62
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v471201_10q.htm 10-Q 344986
2 EXHIBIT 31.1 v471201_ex31-1.htm EX-31.1 11502
3 EXHIBIT 31.2 v471201_ex31-2.htm EX-31.2 11375
4 EXHIBIT 32.1 v471201_ex32-1.htm EX-32.1 4327
5 EXHIBIT 32.2 v471201_ex32-2.htm EX-32.2 4183
  Complete submission text file 0001144204-17-041718.txt   3747260

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sbot-20170630.xml EX-101.INS 934422
7 XBRL TAXONOMY EXTENSION SCHEMA sbot-20170630.xsd EX-101.SCH 39574
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbot-20170630_cal.xml EX-101.CAL 34431
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbot-20170630_def.xml EX-101.DEF 205446
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbot-20170630_lab.xml EX-101.LAB 271482
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbot-20170630_pre.xml EX-101.PRE 243528
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 171018411
SIC: 2834 Pharmaceutical Preparations